Nature Medicine, Published online: 28 March 2025; doi:10.1038/s41591-025-03557-2
Two recent, early-phase trials evaluating antibodies that target GDF-15 show positive effects on immunotherapy response and cachexia symptoms; further work to unravel the multifaceted biology of GDF-15 in cancer could lead to transformative treatment strategies.
